據報恆大(03333.HK)上周股價抽高前 對沖基金沽空比率大增
《彭博》報道,經過最近數月的減少押注後,對沖基金及其他沽空人士在上周再次對中國恆大(03333.HK)進行沽空狙擊,於9月29日(上周二)加大沽空恆大股票比率近一倍,不過由於市場對公司現金緊張的憂慮減輕,該股翌日(30日)即上升了19%。
報道指,恆大早於2017年已斥數以十億元資金作回購,對戰狙擊公司股票的沽空者,結果恆大當年股價大升458%,表現為485隻恆生綜合指數股份中最好。
另外,根據IHS Markit數據,公司本周一(8日)自由流通量的沽空比率高達18.5%,為去年4月以來最高,而沽空比率於2018年曾升至27%。恆大主席許家印持有公司流通股份逾70%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.